Perrigo - 34 Year Stock Price History | PRGO
Historical daily share price chart and data for Perrigo since 1991 adjusted for splits and dividends. The latest closing stock price for Perrigo as of March 27, 2025 is 27.75.
- The all-time high Perrigo stock closing price was 171.55 on April 14, 2015.
- The Perrigo 52-week high stock price is 33.45, which is 20.5% above the current share price.
- The Perrigo 52-week low stock price is 23.14, which is 16.6% below the current share price.
- The average Perrigo stock price for the last 52 weeks is 27.29.
| Perrigo Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 25.8597 | 26.0000 | 29.4700 | 23.5000 | 27.7500 | 7.93% |
| 2024 | 28.1560 | 32.2439 | 33.1868 | 23.9484 | 25.7100 | -17.81% |
| 2023 | 32.4228 | 33.1273 | 38.1822 | 25.9937 | 31.2815 | -2.47% |
| 2022 | 34.8767 | 35.9134 | 39.8317 | 29.2793 | 32.0736 | -9.80% |
| 2021 | 39.1869 | 39.8551 | 44.3880 | 32.5510 | 35.5569 | -10.96% |
| 2020 | 45.3175 | 45.0133 | 53.3594 | 35.8391 | 39.9354 | -11.92% |
| 2019 | 43.0092 | 34.9327 | 49.5568 | 34.3893 | 45.3380 | 35.65% |
| 2018 | 65.0208 | 76.7846 | 81.4590 | 31.4826 | 33.4233 | -55.21% |
| 2017 | 66.3894 | 73.4451 | 76.0629 | 56.2777 | 74.6186 | 5.59% |
| 2016 | 88.4102 | 120.2757 | 125.8126 | 67.7718 | 70.6686 | -42.14% |
| 2015 | 144.8728 | 140.2248 | 171.5523 | 121.7781 | 122.1326 | -13.18% |
| 2014 | 127.0665 | 128.4801 | 142.0173 | 106.5368 | 140.6708 | 9.23% |
| 2013 | 104.5768 | 89.2914 | 131.6523 | 83.0491 | 128.7822 | 47.94% |
| 2012 | 89.3371 | 82.2043 | 100.2986 | 77.6832 | 87.0489 | 7.25% |
| 2011 | 71.9488 | 52.9607 | 85.4741 | 52.5118 | 81.1616 | 54.17% |
| 2010 | 47.8791 | 33.3891 | 56.5269 | 31.2624 | 52.6448 | 59.73% |
| 2009 | 24.4210 | 25.9555 | 33.7945 | 15.5466 | 32.9588 | 24.27% |
| 2008 | 28.4311 | 27.7433 | 34.6145 | 23.1597 | 26.5219 | -7.16% |
| 2007 | 17.4081 | 14.2473 | 29.5303 | 13.1732 | 28.5674 | 104.10% |
| 2006 | 13.1004 | 12.1355 | 14.9606 | 11.6219 | 13.9965 | 17.27% |
| 2005 | 12.3990 | 13.4537 | 15.6669 | 10.2638 | 11.9354 | -12.72% |
| 2004 | 14.9339 | 12.4811 | 18.2602 | 12.3946 | 13.6755 | 10.69% |
| 2003 | 10.9081 | 9.7388 | 12.8526 | 8.4548 | 12.3553 | 30.42% |
| 2002 | 9.2541 | 9.5439 | 11.4543 | 7.3841 | 9.4737 | 2.79% |
| 2001 | 10.0444 | 6.4328 | 14.2613 | 6.3844 | 9.2164 | 42.74% |
| 2000 | 5.4967 | 6.3314 | 7.0667 | 4.0203 | 6.4570 | 3.51% |
| 1999 | 6.4639 | 6.9201 | 7.5049 | 5.6531 | 6.2379 | -9.22% |
| 1998 | 7.9645 | 11.0176 | 11.1112 | 5.8480 | 6.8718 | -34.13% |
| 1997 | 10.0324 | 7.0176 | 13.2554 | 7.0176 | 10.4328 | 46.71% |
| 1996 | 8.4942 | 9.4503 | 11.1112 | 6.8227 | 7.1112 | -23.23% |
| 1995 | 9.6143 | 9.3568 | 10.8227 | 8.2885 | 9.2632 | -4.96% |
| 1994 | 14.2051 | 26.7058 | 26.7058 | 8.5770 | 9.7466 | -63.50% |
| 1993 | 19.8750 | 17.2516 | 26.7058 | 15.1073 | 26.7058 | 52.22% |
| 1992 | 12.9804 | 11.1112 | 17.5440 | 9.3100 | 17.5440 | 51.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.443B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |